Innovating, Advocating & Helping Keep Americans Safe
Response to Representatives Hudson (R-NC) and Eshoo (D-CA) PAHPA Request for Information (RFI)
Response to Senate Committee on Health, Education, Labor, and Pensions ("HELP") PAHPA RFI
-
Alliance for Biosecurity Written Comments on U.S. International Trade Commission's Proposed Intellectual Property Waiver Expansion (May 5, 2023)
-
Alliance Cautions European Commission on EU General Pharmaceutical Legislation Revisions (April 25, 2023)Al
Alliance for Biosecurity Opposes Efforts to Expand Intellectual Property Waivers; Urges U.S. Trade Leaders to Prioritize America's National Security
May 2023
April 2023
Alliance for Biosecurity Advises Congress on Upcoming PAHPA Reauthorization
April 2022
Alliance for Biosecurity Applauds Inclusion of the PREVENT Pandemics Act in the Omnibus Legislation
Dec 2022
Alliance for Biosecurity Mission
The Alliance for Biosecurity promotes a stronger, more effective partnership between government, the biopharmaceutical industry, and other stakeholders in order to advance their shared goal of developing critically needed medical countermeasures. The Alliance also seeks to develop sound public policy proposals that could bolster national efforts to rapidly develop, produce, stockpile, and distribute medical countermeasures. Read more here.